Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 23, Issue 2, Pages 162-173
Publisher
Wiley
Online
2016-12-10
DOI
10.1111/cns.12660
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function
- (2016) Max Sloan et al. HUMAN MOLECULAR GENETICS
- Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
- (2015) Anthony A. Estrada et al. JOURNAL OF MEDICINAL CHEMISTRY
- LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
- (2015) Insup Choi et al. Nature Communications
- Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models
- (2014) T. Li et al. HUMAN MOLECULAR GENETICS
- LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism
- (2014) A. M. Arranz et al. JOURNAL OF CELL SCIENCE
- The Upshot of LRRK2 Inhibition to Parkinson’s Disease Paradigm
- (2014) A. R. Esteves et al. MOLECULAR NEUROBIOLOGY
- Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
- (2014) Iakov N. Rudenko et al. Neurotherapeutics
- The development of CNS-active LRRK2 inhibitors using property-directed optimisation
- (2013) Madeline E. Kavanagh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1
- (2013) Gregory C. Luerman et al. JOURNAL OF NEUROCHEMISTRY
- Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
- (2013) Mareike Caesar et al. NEUROBIOLOGY OF DISEASE
- Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2
- (2012) Youren Tong et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
- (2012) Alastair D. Reith et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
- (2012) Iakov N Rudenko et al. BMC Medicine
- GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2
- (2012) A. Biosa et al. HUMAN MOLECULAR GENETICS
- G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization
- (2012) Tatiana D. Papkovskaia et al. HUMAN MOLECULAR GENETICS
- Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
- (2012) C. Yao et al. HUMAN MOLECULAR GENETICS
- Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
- (2012) Anthony A. Estrada et al. JOURNAL OF MEDICINAL CHEMISTRY
- LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
- (2012) Daniel F Marker et al. Journal of Neuroinflammation
- LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
- (2012) Samer Matta et al. NEURON
- Regulation of Presynaptic Neurotransmission by Macroautophagy
- (2012) Daniela Hernandez et al. NEURON
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
- (2012) Byoung Dae Lee et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Role of LRRK2 kinase dysfunction in Parkinson disease
- (2011) Azad Kumar et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Molecular and functional differences in voltage-activated sodium currents between GABA projection neurons and dopamine neurons in the substantia nigra
- (2011) Shengyuan Ding et al. JOURNAL OF NEUROPHYSIOLOGY
- A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2
- (2011) J. Dusonchet et al. JOURNAL OF NEUROSCIENCE
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- (2010) Byoung Dae Lee et al. NATURE MEDICINE
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice
- (2010) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started